RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Hepatitis C (INACTIVE)

A collection of news and information related to Hepatitis C (INACTIVE) published by this site and its partners.

Top Hepatitis C (INACTIVE) Articles

Displaying items 25-36
  • Med tech accused in hepatitis C case pleads not guilty

    Med tech accused in hepatitis C case pleads not guilty
    A traveling hospital worker accused of stealing pain-killing drugs, contaminating syringes and infecting dozens of patients with hepatitis C pleaded not guilty to the charges in New Hampshire federal court Monday. David Kwiatkowski, 33, who was trained...
  • Congress must restore federal funding for needle exchange

    Congress must restore federal funding for needle exchange
    In 2009, Congress passed legislation reversing the decades-old ban on the use of federal funding for syringe exchange but, for unclear reasons, in late 2011, it reversed this decision, again withholding federal funding from programs that provide drug...
  • Police turn out at blood drive in honor of injured officer

    Police turn out at blood drive in honor of injured officer
    Those who work in public safety consider themselves part of a brotherhood. But for the purposes of organ donation, a brother in blue may not be quite family enough, as Officer Gene Cassidy is finding out. Cassidy was shot in the head 27 years ago in West...
  • David Simon's 'Homicide' cop battling life on the streets once again

    David Simon's 'Homicide' cop battling life on the streets once again
    March 11, 2012 Seven-baker-twenty-four unit turns at Mosher and rumbles past that stretch of Appleton Street where Gene Cassidy took two in the head for the company, the first one stealing his eyesight, the second lodging in his brain beyond the skill...
  • Advisory panel calls for end to most experiments on chimpanzees

    Advisory panel calls for end to most experiments on chimpanzees
    Medical experiments on chimpanzees are largely unnecessary and should be rare, concluded a report released Thursday from special panel of the Institute of Medicine, part of the National Academies of Science. The authors did not recommend an outright ban,...
  • OMS pide que nueva medicación contra la hepatitis C sea más barata

    Por Ben Hirschler LONDRES (Reuters) - La Organización Mundial de la Salud (OMS) quiere un "esfuerzo concertado" para reducir el costo de los nuevos fármacos contra la hepatitis C, que ofrecen una cura para la enfermedad viral que destruye el hígado...
  • 10 medical innovations set to reshape patient care this year

    Source: Cleveland Clinic whatdoctorsknow.com The Cleveland Clinic asked 100 of its top experts -- people who focus on patient care every day -- to offer insights on which medical breakthroughs are set to reshape healthcare this year. Here are their...
  • J&J accepts $4B Carlyle offer for diagnostics unit

    NEW BRUNSWICK, N.J. — Johnson & Johnson has accepted an offer of about $4 billion from the private equity firm the Carlyle Group to buy its Ortho-Clinical Diagnostics business. J&J said Monday that the deal for the blood-testing unit should close...
  • LVHN hosting wellness conference for women

    Lehigh Valley Health Network invites women of all ages to attend the Women's Wellness Conference 2014 from 11 a.m. to 3 p.m. Saturday, Mar. 29. The event focuses on education to limit exposure to HIV, hepatitis C and sexually transmitted diseases. Free...
  • California sticks with March 31 deadline for Obamacare -- for now

    California sticks with March 31 deadline for Obamacare -- for now
    California says March 31 remains the deadline to apply for Obamacare, but the state will give residents who start an application by then until April 15 to finish signing up. Wednesday, the Obama administration said it would allow consumers using the...
  • Gilead Sciences' $84,000 price for hepatitis drug is scrutinized

    Gilead Sciences' $84,000 price for hepatitis drug is scrutinized
    U.S. lawmakers have asked Gilead Sciences Inc. to justify the price of its new $84,000 drug for hepatitis C patients amid growing concern about the high cost to taxpayers and consumers. In a letter to the Foster City, Calif., company, Rep. Henry A....
  • Should prisoners get expensive hepatitis C drugs?

    WASHINGTON If used widely, a new generation of antiviral drugs has the potential to wipe out the deadly hepatitis C virus in the United States. But the high price of the drugs might prevent their use in prisons, which house as many as one-third of those...